Loading...

Kristin Cadenhead

Title(s)Professor, Psychiatry
SchoolHealth Sciences
Phone619-543-6445
vCardDownload vCard

    Collapse Overview 
    Collapse Overview

    Biography

    Dr. Kristin Cadenhead a Professor of Psychiatry at University of California San Diego and an attending physician at both the Veterans Administration and the UCSD Medical Centers. She serves as an Associate Residency Training Director for the Department of Psychiatry and a Clinical Foundations Director for the School of Medicine. She is the Director of the Cognitive Assessment and Risk Evaluation (CARE) Program, a research and clinical program that focuses on early identification, intervention and prevention of serious mental illness. Dr. Cadenhead is the Medical Director of the Mental Health Primary Care clinic at the VA Medical Center. She received her BA degree in Biology/Psychology from Rice University in Houston, Texas. She then earned her medical degree from the University of Texas Medical Branch in Galveston. She completed her residency in Psychiatry and Fellowship in Schizophrenia research at UCSD.

    Research Interests

    Primary research interests include vulnerability markers in the schizophrenia spectrum of disorders (prodromal schizophrenia and schizotypal personality disorder) and the genetics of schizophrenia. Dr. Cadenhead is the Director of the “CARE” (Cognitive Assessment and Risk Evaluation) Program to study the early signs of psychosis in adolescents and young adults. Funded by the National Institutes of Health, the CARE program provides education and community outreach to the National Alliance for the Mentally Ill, the San Diego Public Schools and other community health and physician organizations. The study is longitudinal and assesses clinical as well as physiologic and cognitive factors that may be predictive of developing schizophrenia. A major aim of the CARE program is to identify psychosis early so that it is possible to intervene earlier and perhaps prevent some of the devastating effects of schizophrenia. Dr. Cadenhead is also interested in the heritability of the information processing traits and participates in ongoing studies in normal twins. Dr. Cadenhead has expertise in the treatment of psychotic disorders and provides regular consultations.

    Clinical Focus

    The CARE Program provides clinical care to individuals who are developing the initial signs of a psychotic illness. The treatment philosophy includes a multidisciplinary approach with pharmacologic management, social services, stress management and psychoeducation as part of the program. Dr. Cadenhead is also the Director of the Psychiatry Primary Care Clinic at the SDVAMC. The Primary Care Clinic is staffed by psychiatry residents who provide both psychiatric and primary care to psychiatric patients while they are supervised by Attending Physicians in Psychiatry and Internal Medicine.

    Collapse Research 
    Collapse Research Activities and Funding
    3/3-Cognitive Behavioral Social Skills Training for Youth at Risk of Psychosis
    NIH/NIMH R01MH105243Sep 26, 2014 - Jul 31, 2019
    Role: Principal Investigator
    Compensatory Cognitive Training in Clinical High Risk Latino Youth
    NIH/NIMH R34MH105247Sep 12, 2014 - Jun 30, 2018
    Role: Principal Investigator
    Inflammatory Biomarkers in First Episode Psychosis: A Mexico/US Collaboration
    NIH/NIMH R21MH102374May 1, 2014 - Apr 30, 2016
    Role: Principal Investigator
    6/9-Predictors and Mechanisms of Conversion to Psychosis
    NIH/NIMH U01MH081944Dec 1, 2007 - Jun 30, 2019
    Role: Principal Investigator
    Vulnerability Markers in the Prodrome and First Episode of Schizophrenia
    NIH/NIMH K24MH076191Sep 29, 2007 - Jun 30, 2013
    Role: Principal Investigator
    Vulnerability Markers in Prodromal Schizophrenia
    NIH/NIMH R01MH060720Dec 1, 1999 - Apr 30, 2012
    Role: Principal Investigator
    INFORMATION PROCESSING DEFICITS IN SCHIZOTYPAL PATIENTS
    NIH/NIMH K20MH001124Apr 1, 1995 - Mar 31, 2001
    Role: Principal Investigator
    THE SCHIZOPHRENIC SPECTRUM AND INFORMATION PROCESSING
    NIH/NIMH F32MH010072Jul 28, 1991
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Perkins DO, Olde Loohuis L, Barbee J, Ford J, Jeffries CD, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang M, Walker EF, Woods SW. Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High Risk. Am J Psychiatry. 2019 Nov 12; appiajp201918060721. PMID: 31711302.
      View in: PubMed
    2. Allswede DM, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan T, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cannon TD. Characterizing Covariant Trajectories of Individuals at Clinical High Risk for Psychosis Across Symptomatic and Functional Domains. Am J Psychiatry. 2019 Sep 06; appiajp201918111290. PMID: 31509005.
      View in: PubMed
    3. Hamilton HK, Roach BJ, Bachman PM, Belger A, Carrion RE, Duncan E, Johannesen JK, Light GA, Niznikiewicz MA, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cannon TD, Mathalon DH. Association Between P300 Responses to Auditory Oddball Stimuli and Clinical Outcomes in the Psychosis Risk Syndrome. JAMA Psychiatry. 2019 Aug 07. PMID: 31389974.
      View in: PubMed
    4. Goines KB, LoPilato AM, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Woods SW, Walker EF. Sleep problems and attenuated psychotic symptoms in youth at clinical high-risk for psychosis. Psychiatry Res. 2019 Aug 03; 112492. PMID: 31387769.
      View in: PubMed
    5. Cao H, McEwen SC, Chung Y, Chén OY, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Carrión RE, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos H, Tsuang MT, van Erp TGM, Walker EF, Hamann S, Anticevic A, Woods SW, Cannon TD. Altered Brain Activation During Memory Retrieval Precedes and Predicts Conversion to Psychosis in Individuals at Clinical High Risk. Schizophr Bull. 2019 Jun 18; 45(4):924-933. PMID: 30215784.
      View in: PubMed
    6. Carrión RE, Auther AM, McLaughlin D, Olsen R, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cornblatt BA. The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis. Schizophr Bull. 2019 Jun 18; 45(4):763-772. PMID: 30351423.
      View in: PubMed
    7. Chung Y, Allswede D, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, McEwen S, van Erp TGM, Cannon TD. Cortical abnormalities in youth at clinical high-risk for psychosis: Findings from the NAPLS2 cohort. Neuroimage Clin. 2019; 23:101862. PMID: 31150956.
      View in: PubMed
    8. LoPilato AM, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Woods SW, Walker EF. Stress perception following childhood adversity: Unique associations with adversity type and sex. Dev Psychopathol. 2019 Mar 08; 1-14. PMID: 30846020.
      View in: PubMed
    9. Cao H, McEwen SC, Forsyth JK, Gee DG, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Carrión RE, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos H, Tsuang MT, van Erp TGM, Walker EF, Hamann S, Anticevic A, Woods SW, Cannon TD. Toward Leveraging Human Connectomic Data in Large Consortia: Generalizability of fMRI-Based Brain Graphs Across Sites, Sessions, and Paradigms. Cereb Cortex. 2019 Mar 01; 29(3):1263-1279. PMID: 29522112.
      View in: PubMed
    10. Foss-Feig JH, Velthorst E, Smith L, Reichenberg A, Addington J, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone WS, Keshavan M, Tsuang MT, Walker EF, Woods SW, Cannon TD, Bearden CE. Clinical Profiles and Conversion Rates Among Young Individuals With Autism Spectrum Disorder Who Present to Clinical High Risk for Psychosis Services. J Am Acad Child Adolesc Psychiatry. 2019 Jun; 58(6):582-588. PMID: 30797038.
      View in: PubMed
    11. Brodey BB, Girgis RR, Favorov OV, Bearden CE, Woods SW, Addington J, Perkins DO, Walker EF, Cornblatt BA, Brucato G, Purcell SE, Brodey IS, Cadenhead KS. The Early Psychosis Screener for Internet (EPSI)-SR: Predicting 12?month psychotic conversion using machine learning. Schizophr Res. 2019 Jun; 208:390-396. PMID: 30777603.
      View in: PubMed
    12. LoPilato AM, Goines K, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman L, Perkins DO, Tsuang MT, Woods SW, Walker EF. Impact of childhood adversity on corticolimbic volumes in youth at clinical high-risk for psychosis. Schizophr Res. 2019 Feb 07. PMID: 30745068.
      View in: PubMed
    13. Chung Y, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, McEwen S, van Erp TGM, Cannon TD. Adding a neuroanatomical biomarker to an individualized risk calculator for psychosis: A proof-of-concept study. Schizophr Res. 2019 Jun; 208:41-43. PMID: 30745066.
      View in: PubMed
    14. Cao H, Chung Y, McEwen SC, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Carrión R, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos H, Tsuang MT, van Erp TGM, Walker EF, Hamann S, Anticevic A, Woods SW, Cannon TD. Progressive reconfiguration of resting-state brain networks as psychosis develops: Preliminary results from the North American Prodrome Longitudinal Study (NAPLS) consortium. Schizophr Res. 2019 Jan 28. PMID: 30704864.
      View in: PubMed
    15. Goldsmith DR, Haroon E, Miller AH, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, Mathalon D, McGlashan T, Seidman L, Tsuang M, Woods SW, Walker EF, Perkins DO. Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis. Brain Behav Immun. 2019 02; 76:268-274. PMID: 30496778.
      View in: PubMed
    16. Ward HB, Lawson MT, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Jeffries CD, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Perkins DO. Tobacco use and psychosis risk in persons at clinical high risk. Early Interv Psychiatry. 2019 10; 13(5):1173-1181. PMID: 30362261.
      View in: PubMed
    17. Cadenhead KS, Minichino A, Kelsven S, Addington J, Bearden C, Cannon TD, Cornblatt BA, Mathalon D, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Yao J. Metabolic abnormalities and low dietary Omega 3 are associated with symptom severity and worse functioning prior to the onset of psychosis: Findings from the North American Prodrome Longitudinal Studies Consortium. Schizophr Res. 2019 02; 204:96-103. PMID: 30249470.
      View in: PubMed
    18. Cao H, Chén OY, Chung Y, Forsyth JK, McEwen SC, Gee DG, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Carrión RE, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos H, Tsuang MT, van Erp TGM, Walker EF, Hamann S, Anticevic A, Woods SW, Cannon TD. Cerebello-thalamo-cortical hyperconnectivity as a state-independent functional neural signature for psychosis prediction and characterization. Nat Commun. 2018 09 21; 9(1):3836. PMID: 30242220.
      View in: PubMed
    19. Addington J, Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Bearden CE, Mathalon DH, Santesteban-Echarri O, Woods SW. Clinical and functional characteristics of youth at clinical high-risk for psychosis who do not transition to psychosis. Psychol Med. 2019 Jul; 49(10):1670-1677. PMID: 30176955.
      View in: PubMed
    20. Chung Y, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, McEwen S, van Erp TGM, Cannon TD. Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk. JAMA Psychiatry. 2018 09 01; 75(9):960-968. PMID: 29971330.
      View in: PubMed
    21. Shakeel MK, Lu L, Cannon TD, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Walker EF, Mathalon DH, Bearden CE, Addington J. Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: An outcome based analysis. Schizophr Res. 2019 02; 204:334-336. PMID: 30181061.
      View in: PubMed
    22. Velthorst E, Meyer EC, Giuliano AJ, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Bearden CE, Seidman LJ. Neurocognitive profiles in the prodrome to psychosis in NAPLS-1. Schizophr Res. 2019 02; 204:311-319. PMID: 30078717.
      View in: PubMed
    23. Hampton JN, Trotman HD, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Tsuang MT, Perkins DO, Seidman LJ, Woods SW, Walker EF. The relation of atypical antipsychotic use and stress with weight in individuals at clinical high risk for psychosis. Stress Health. 2018 Dec; 34(5):591-600. PMID: 29956456.
      View in: PubMed
    24. Jeffries CD, Perkins DO, Fournier M, Do KQ, Cuenod M, Khadimallah I, Domenici E, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang M, Walker EF, Woods SW. Networks of blood proteins in the neuroimmunology of schizophrenia. Transl Psychiatry. 2018 06 06; 8(1):112. PMID: 29875399.
      View in: PubMed
    25. Woods SW, Powers AR, Taylor JH, Davidson CA, Johannesen JK, Addington J, Perkins DO, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. Lack of Diagnostic Pluripotentiality in Patients at Clinical High Risk for Psychosis: Specificity of Comorbidity Persistence and Search for Pluripotential Subgroups. Schizophr Bull. 2018 02 15; 44(2):254-263. PMID: 29036402.
      View in: PubMed
    26. Ryan AT, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Cannon TD, Walker EF. Latent class cluster analysis of symptom ratings identifies distinct subgroups within the clinical high risk for psychosis syndrome. Schizophr Res. 2018 07; 197:522-530. PMID: 29279247.
      View in: PubMed
    27. Stowkowy J, Liu L, Cadenhead KS, Tsuang MT, Cannon TD, Cornblatt BA, McGlashan TH, Woods SW, Perkins DO, Seidman LJ, Walker EF, Bearden CE, Mathalon DH, Addington J. Exploration of clinical high-risk dropouts. Schizophr Res. 2018 05; 195:579-580. PMID: 28964651.
      View in: PubMed
    28. Lu Y, Marshall C, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. Perceptual abnormalities in clinical high risk youth and the role of trauma, cannabis use and anxiety. Psychiatry Res. 2017 12; 258:462-468. PMID: 28886901.
      View in: PubMed
    29. Georgopoulos G, Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. The role of a family history of psychosis for youth at clinical high risk of psychosis. Early Interv Psychiatry. 2019 Apr; 13(2):251-256. PMID: 28792113.
      View in: PubMed
    30. Marshall C, Lu Y, Lyngberg K, Deighton S, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. Changes in symptom content from a clinical high-risk state to conversion to psychosis. Early Interv Psychiatry. 2019 Apr; 13(2):257-263. PMID: 28771938.
      View in: PubMed
    31. Kline ER, Seidman LJ, Cornblatt BA, Woodberry KA, Bryant C, Bearden CE, Cadenhead KS, Cannon TD, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Addington J. Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort. Schizophr Res. 2018 02; 192:357-363. PMID: 28578922.
      View in: PubMed
    32. Velthorst E, Zinberg J, Addington J, Cadenhead KS, Cannon TD, Carrión RE, Auther A, Cornblatt BA, McGlashan TH, Mathalon DH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Reichenberg A, Bearden CE. Potentially important periods of change in the development of social and role functioning in youth at clinical high risk for psychosis. Dev Psychopathol. 2018 02; 30(1):39-47. PMID: 28420458.
      View in: PubMed
    33. Addington J, Piskulic D, Liu L, Lockwood J, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Bearden CE, Mathalon DH, Woods SW. Comorbid diagnoses for youth at clinical high risk of psychosis. Schizophr Res. 2017 12; 190:90-95. PMID: 28372906.
      View in: PubMed
    34. Minichino A, Ando' A, Francesconi M, Salatino A, Delle Chiaie R, Cadenhead K. Investigating the link between drug-naive first episode psychoses (FEPs), weight gain abnormalities and brain structural damages: Relevance and implications for therapy. Prog Neuropsychopharmacol Biol Psychiatry. 2017 07 03; 77:9-22. PMID: 28363765.
      View in: PubMed
    35. Chung Y, Haut KM, He G, van Erp TGM, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, Cannon TD. Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosis. Schizophr Res. 2017 11; 189:169-174. PMID: 28245961.
      View in: PubMed
    36. Zheutlin AB, Jeffries CD, Perkins DO, Chung Y, Chekroud AM, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Walker EF, Woods SW, Tsuang M, Cannon TD. The Role of microRNA Expression in Cortical Development During Conversion to Psychosis. Neuropsychopharmacology. 2017 Oct; 42(11):2188-2195. PMID: 28186095.
      View in: PubMed
    37. Minichino A, Francesconi M, Carrión RE, Delle Chiaie R, Bevilacqua A, Parisi M, Rullo S, Bersani FS, Biondi M, Cadenhead K. From neurological soft signs to functional outcome in young individuals in treatment with secondary services for non-psychotic disorders: a path analysis. Psychol Med. 2017 May; 47(7):1192-1203. PMID: 28052777.
      View in: PubMed
    38. Minichino A, Cadenhead K. Mirror Neurons in Psychiatric Disorders: from Neuroception to Bio-behavioral System Dysregulation. Neuropsychopharmacology. 2017 01; 42(1):366. PMID: 27909332.
      View in: PubMed
    39. Minichino A, Francesconi M, Carrión RE, Bevilacqua A, Parisi M, Rullo S, Ando' A, Biondi M, Delle Chiaie R, Cadenhead K. Prediction of functional outcome in young patients with a recent-onset psychiatric disorder: Beyond the traditional diagnostic classification system. Schizophr Res. 2017 07; 185:114-121. PMID: 28041918.
      View in: PubMed
    40. Francesconi M, Minichino A, Carrión RE, Delle Chiaie R, Bevilacqua A, Parisi M, Rullo S, Bersani FS, Biondi M, Cadenhead K. Psychosis prediction in secondary mental health services. A broad, comprehensive approach to the "at risk mental state" syndrome. Eur Psychiatry. 2017 02; 40:96-104. PMID: 27992839.
      View in: PubMed
    41. Jeffries CD, Perkins DO, Chandler SD, Stark T, Yeo E, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Walker EF, Woods SW, Glatt SJ, Tsuang M. Insights into psychosis risk from leukocyte microRNA expression. Transl Psychiatry. 2016 12 13; 6(12):e981. PMID: 27959328.
      View in: PubMed
    42. Seidman LJ, Shapiro DI, Stone WS, Woodberry KA, Ronzio A, Cornblatt BA, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study. JAMA Psychiatry. 2016 Dec 01; 73(12):1239-1248. PMID: 27806157.
      View in: PubMed
    43. Noble S, Scheinost D, Finn ES, Shen X, Papademetris X, McEwen SC, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet DM, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos H, Tsuang MT, van Erp TGM, Walker EF, Hamann S, Woods SW, Cannon TD, Constable RT. Multisite reliability of MR-based functional connectivity. Neuroimage. 2017 02 01; 146:959-970. PMID: 27746386.
      View in: PubMed
    44. Francesconi M, Minichino A, Carrión RE, Chiaie RD, Bevilacqua A, Parisi M, Rullo S, Bersani FS, Biondi M, Cadenhead K. Theory of Mind as a mediator variable between neurocognition and functioning in young individuals in treatment with secondary services for non-psychotic disorders. Psychiatry Res. 2016 Dec 30; 246:415-420. PMID: 27788462.
      View in: PubMed
    45. Woodberry KA, Seidman LJ, Bryant C, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Mathalon DH, Perkins DO, Tsuang MT, Walker EF, Woods SW. Treatment Precedes Positive Symptoms in North American Adolescent and Young Adult Clinical High Risk Cohort. J Clin Child Adolesc Psychol. 2018 Jan-Feb; 47(1):69-78. PMID: 27705009.
      View in: PubMed
    46. Cannon TD, Yu C, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Heinssen R, Jeffries CD, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Kattan MW. An Individualized Risk Calculator for Research in Prodromal Psychosis. Am J Psychiatry. 2016 Oct 01; 173(10):980-988. PMID: 27363508.
      View in: PubMed
    47. Buchy L, Mathalon DH, Cannon TD, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Addington J. Relation between cannabis use and subcortical volumes in people at clinical high risk of psychosis. Psychiatry Res Neuroimaging. 2016 Aug 30; 254:3-9. PMID: 27289213.
      View in: PubMed
    48. Marshall C, Deighton S, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. The Violent Content in Attenuated Psychotic Symptoms. Psychiatry Res. 2016 Aug 30; 242:61-66. PMID: 27259137.
      View in: PubMed
    49. Deighton S, Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. Traumatic brain injury in individuals at clinical high risk for psychosis. Schizophr Res. 2016 07; 174(1-3):77-81. PMID: 27165121.
      View in: PubMed
    50. Millard SP, Shofer J, Braff D, Calkins M, Cadenhead K, Freedman R, Green MF, Greenwood TA, Gur R, Gur R, Lazzeroni LC, Light GA, Olincy A, Nuechterlein K, Seidman L, Siever L, Silverman J, Stone WS, Sprock J, Sugar CA, Swerdlow NR, Tsuang M, Turetsky B, Radant A, Tsuang DW. Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family study. Schizophr Res. 2016 07; 174(1-3):1-9. PMID: 27132484.
      View in: PubMed
    51. McLaughlin D, Carrión RE, Auther AM, Olvet DM, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Heinssen RK, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Goldberg TE, Harvey PD, Cornblatt BA. Functional Capacity Assessed by the Map Task in Individuals at Clinical High-Risk for Psychosis. Schizophr Bull. 2016 09; 42(5):1234-42. PMID: 27105902.
      View in: PubMed
    52. Cadenhead KS, Mirzakhanian H. A Case of Attenuated Psychosis Syndrome: A Broad Differential Diagnosis Requires Broad-Spectrum Treatment. Am J Psychiatry. 2016 Apr 01; 173(4):321-9. PMID: 27035531.
      View in: PubMed
    53. Millan MJ, Andrieux A, Bartzokis G, Cadenhead K, Dazzan P, Fusar-Poli P, Gallinat J, Giedd J, Grayson DR, Heinrichs M, Kahn R, Krebs MO, Leboyer M, Lewis D, Marin O, Marin P, Meyer-Lindenberg A, McGorry P, McGuire P, Owen MJ, Patterson P, Sawa A, Spedding M, Uhlhaas P, Vaccarino F, Wahlestedt C, Weinberger D. Altering the course of schizophrenia: progress and perspectives. Nat Rev Drug Discov. 2016 07; 15(7):485-515. PMID: 26939910.
      View in: PubMed
    54. Moskow DM, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Heinssen R, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Cannon TD, Woods SW, Walker EF. The relations of age and pubertal development with cortisol and daily stress in youth at clinical risk for psychosis. Schizophr Res. 2016 Apr; 172(1-3):29-34. PMID: 26905038.
      View in: PubMed
    55. Stone WS, Mesholam-Gately RI, Giuliano AJ, Woodberry KA, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, McCarley RW, Heinssen R, Green MF, Nuechterlein K, Seidman LJ. Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers. Schizophr Res. 2016 Apr; 172(1-3):106-13. PMID: 26896388.
      View in: PubMed
    56. Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. Early traumatic experiences, perceived discrimination and conversion to psychosis in those at clinical high risk for psychosis. Soc Psychiatry Psychiatr Epidemiol. 2016 Apr; 51(4):497-503. PMID: 26851943.
      View in: PubMed
    57. Minichino A, Singh F, Pineda J, Friederich E, Cadenhead KS. Biological Motion induced mu suppression is reduced in Early Psychosis (EP) patients with active negative symptoms and Autism Spectrum Disorders (ASD). Psychiatry Res. 2016 Apr 30; 238:374-377. PMID: 26970656.
      View in: PubMed
    58. Piskulic D, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. Social cognition over time in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort. Schizophr Res. 2016 Mar; 171(1-3):176-81. PMID: 26785807.
      View in: PubMed
    59. Singh F, Nunag J, Muldoon G, Cadenhead KS, Pineda JA, Feifel D. Effects of intranasal oxytocin on neural processing within a socially relevant neural circuit. Eur Neuropsychopharmacol. 2016 Mar; 26(3):626-30. PMID: 26727038.
      View in: PubMed
    60. Buchy L, Seidman LJ, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Stone W, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis. Psychiatry Res. 2015 Dec 30; 230(3):878-84. PMID: 26626949.
      View in: PubMed
    61. Buchy L, Cannon TD, Anticevic A, Lyngberg K, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis. BMC Psychiatry. 2015 Nov 09; 15:276. PMID: 26553191.
      View in: PubMed
    62. McAusland L, Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. Anxiety in youth at clinical high risk for psychosis. Early Interv Psychiatry. 2017 12; 11(6):480-487. PMID: 26456932.
      View in: PubMed
    63. Perkins DO, Jeffries CD, Cornblatt BA, Woods SW, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Heinssen R, Mathalon DH, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. Severity of thought disorder predicts psychosis in persons at clinical high-risk. Schizophr Res. 2015 Dec; 169(1-3):169-177. PMID: 26441004.
      View in: PubMed
    64. Anticevic A, Haut K, Murray JD, Repovs G, Yang GJ, Diehl C, McEwen SC, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet D, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Tsuang MT, van Erp TG, Walker EF, Hamann S, Woods SW, Qiu M, Cannon TD. Association of Thalamic Dysconnectivity and Conversion to Psychosis in Youth and Young Adults at Elevated Clinical Risk. JAMA Psychiatry. 2015 Sep; 72(9):882-91. PMID: 26267151.
      View in: PubMed
    65. Webb JR, Addington J, Perkins DO, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen RK, Seidman LJ, Tarbox SI, Tsuang MT, Walker EF, McGlashan TH, Woods SW. Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis. Schizophr Bull. 2015 Sep; 41(5):1066-75. PMID: 26272875.
      View in: PubMed
    66. Waford RN, MacDonald A, Goines K, Novacek DM, Trotman HD, Elaine F W, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Mathalon DH, Tsuang MT, Perkins DO, Seidman LJ, Woods SW, McGlashan TH. Demographic correlates of attenuated positive psychotic symptoms. Schizophr Res. 2015 Aug; 166(1-3):31-6. PMID: 25999040.
      View in: PubMed
    67. Barbato M, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Heinssen R, Addington J. Theory of Mind, Emotion Recognition and Social Perception in Individuals at Clinical High Risk for Psychosis: findings from the NAPLS-2 cohort. Schizophr Res Cogn. 2015 Sep; 2(3):133-139. PMID: 27695675.
      View in: PubMed
    68. Chung Y, Jacobson A, He G, van Erp TG, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, Heinssen R, Cannon TD. Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion Among Clinically High Risk Youth Developing Psychotic Disorders. Mol Neuropsychiatry. 2015 May 01; 1(1):13-22. PMID: 26005673.
      View in: PubMed
    69. Addington J, Liu L, Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, McGlashan TH. North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms. J Nerv Ment Dis. 2015 May; 203(5):328-35. PMID: 25919383.
      View in: PubMed
    70. Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Heinssen R, Addington J. Core Schemas in Youth at Clinical High Risk for Psychosis. Behav Cogn Psychother. 2016 Mar; 44(2):203-13. PMID: 25896713.
      View in: PubMed
    71. Gee DG, McEwen SC, Forsyth JK, Haut KM, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet D, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos H, Tsuang MT, van Erp TG, Walker EF, Hamann S, Woods SW, Constable T, Cannon TD. Reliability of an fMRI paradigm for emotional processing in a multisite longitudinal study. Hum Brain Mapp. 2015 Jul; 36(7):2558-79. PMID: 25821147.
      View in: PubMed
    72. Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R, Bearden CE, Mathalon D, Addington J. Substance use in individuals at clinical high risk of psychosis. Psychol Med. 2015 Aug; 45(11):2275-84. PMID: 25727300.
      View in: PubMed
    73. Seidman LJ, Hellemann G, Nuechterlein KH, Greenwood TA, Braff DL, Cadenhead KS, Calkins ME, Freedman R, Gur RE, Gur RC, Lazzeroni LC, Light GA, Olincy A, Radant AD, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar C, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Green MF. Factor structure and heritability of endophenotypes in schizophrenia: findings from the Consortium on the Genetics of Schizophrenia (COGS-1). Schizophr Res. 2015 Apr; 163(1-3):73-9. PMID: 25682549.
      View in: PubMed
    74. Auther AM, Cadenhead KS, Carrión RE, Addington J, Bearden CE, Cannon TD, McGlashan TH, Perkins DO, Seidman L, Tsuang M, Walker EF, Woods SW, Cornblatt BA. Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample. Acta Psychiatr Scand. 2015 Jul; 132(1):60-8. PMID: 25572323.
      View in: PubMed
    75. Trotman HD, Holtzman CW, Walker EF, Addington JM, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen RK, Mathalon DH, Tsuang MT, Perkins DO, Seidman LJ, Woods SW, McGlashan TH. Stress exposure and sensitivity in the clinical high-risk syndrome: initial findings from the North American Prodrome Longitudinal Study (NAPLS). Schizophr Res. 2014 Dec; 160(1-3):104-9. PMID: 25443665.
      View in: PubMed
    76. Perkins DO, Jeffries CD, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R. Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project. Schizophr Bull. 2015 Mar; 41(2):419-28. PMID: 25103207.
      View in: PubMed
    77. Solís-Vivanco R, Mondragón-Maya A, León-Ortiz P, Rodríguez-Agudelo Y, Cadenhead KS, de la Fuente-Sandoval C. Mismatch Negativity reduction in the left cortical regions in first-episode psychosis and in individuals at ultra high-risk for psychosis. Schizophr Res. 2014 Sep; 158(1-3):58-63. PMID: 25064664.
      View in: PubMed
    78. Woods SW, Walsh BC, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tarbox SI, Tsuang MT, Walker EF, McGlashan TH. Current status specifiers for patients at clinical high risk for psychosis. Schizophr Res. 2014 Sep; 158(1-3):69-75. PMID: 25012147.
      View in: PubMed
    79. Marshall C, Denny E, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Walker E, Addington J. The content of attenuated psychotic symptoms in those at clinical high risk for psychosis. Psychiatry Res. 2014 Nov 30; 219(3):506-12. PMID: 25048759.
      View in: PubMed
    80. Cannon TD, Chung Y, He G, Sun D, Jacobson A, van Erp TG, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Jeffries C, Seidman LJ, Tsuang M, Walker E, Woods SW, Heinssen R. Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biol Psychiatry. 2015 Jan 15; 77(2):147-57. PMID: 25034946.
      View in: PubMed
    81. Schmeidler J, Lazzeroni LC, Swerdlow NR, Ferreira RP, Braff DL, Calkins ME, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Olincy A, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Stone WS, Sprock J, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Silverman JM. Paternal age of schizophrenia probands and endophenotypic differences from unaffected siblings. Psychiatry Res. 2014 Sep 30; 219(1):67-71. PMID: 24913833.
      View in: PubMed
    82. Forsyth JK, McEwen SC, Gee DG, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet DM, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos HW, Tsuang MT, van Erp TG, Walker EF, Hamann S, Woods SW, Qiu M, Cannon TD. Reliability of functional magnetic resonance imaging activation during working memory in a multi-site study: analysis from the North American Prodrome Longitudinal Study. Neuroimage. 2014 Aug 15; 97:41-52. PMID: 24736173.
      View in: PubMed
    83. Alderman T, Addington J, Bearden C, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cadenhead KS. Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium. Early Interv Psychiatry. 2015 Dec; 9(6):467-75. PMID: 24576057.
      View in: PubMed
    84. Meyer EC, Carrión RE, Cornblatt BA, Addington J, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Heinssen R, Seidman LJ. The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study. Schizophr Bull. 2014 Nov; 40(6):1452-61. PMID: 24550526.
      View in: PubMed
    85. Tsuang D, Esterberg M, Braff D, Calkins M, Cadenhead K, Dobie D, Freedman R, Green MF, Greenwood T, Gur R, Gur R, Horan W, Lazzeroni LC, Light GA, Millard SP, Olincy A, Nuechterlein K, Seidman L, Siever L, Silverman J, Stone W, Sprock J, Sugar C, Swerdlow N, Tsuang M, Turetsky B, Radant A. Is there an association between advanced paternal age and endophenotype deficit levels in schizophrenia? PLoS One. 2014; 9(2):e88379. PMID: 24523888.
      View in: PubMed
    86. Mirzakhanian H, Singh F, Cadenhead KS. Biomarkers in psychosis: an approach to early identification and individualized treatment. Biomark Med. 2014; 8(1):51-7. PMID: 24325224.
      View in: PubMed
    87. Addington J, Case N, Saleem MM, Auther AM, Cornblatt BA, Cadenhead KS. Substance use in clinical high risk for psychosis: a review of the literature. Early Interv Psychiatry. 2014 May; 8(2):104-12. PMID: 24224849.
      View in: PubMed
    88. Tarbox SI, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Heinssen R, McGlashan TH, Woods SW. Premorbid functional development and conversion to psychosis in clinical high-risk youths. Dev Psychopathol. 2013 Nov; 25(4 Pt 1):1171-86. PMID: 24229556.
      View in: PubMed
    89. Tarbox SI, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Heinssen R, McGlashan TH, Woods SW. Functional development in clinical high risk youth: prediction of schizophrenia versus other psychotic disorders. Psychiatry Res. 2014 Jan 30; 215(1):52-60. PMID: 24200216.
      View in: PubMed
    90. Cannon TD, Sun F, McEwen SJ, Papademetris X, He G, van Erp TG, Jacobson A, Bearden CE, Walker E, Hu X, Zhou L, Seidman LJ, Thermenos HW, Cornblatt B, Olvet DM, Perkins D, Belger A, Cadenhead K, Tsuang M, Mirzakhanian H, Addington J, Frayne R, Woods SW, McGlashan TH, Constable RT, Qiu M, Mathalon DH, Thompson P, Toga AW. Reliability of neuroanatomical measurements in a multisite longitudinal study of youth at risk for psychosis. Hum Brain Mapp. 2014 May; 35(5):2424-34. PMID: 23982962.
      View in: PubMed
    91. Cadenhead KS, Dobkins K, McGovern J, Shafer K. Schizophrenia spectrum participants have reduced visual contrast sensitivity to chromatic (red/green) and luminance (light/dark) stimuli: new insights into information processing, visual channel function, and antipsychotic effects. Front Psychol. 2013; 4:535. PMID: 23970874.
      View in: PubMed
    92. Cadenhead KS, Addington J, Cannon TD, Cornblatt BA, de la Fuente-Sandoval C, Mathalon DH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Bachman P, Belger A, Carrión RE, Donkers FC, Duncan E, Johannesen J, León-Ortiz P, Light G, Mondragón A, Niznikiewicz M, Nunag J, Roach BJ, Solís-Vivanco R. Between-site reliability of startle prepulse inhibition across two early psychosis consortia. Neuroreport. 2013 Aug 07; 24(11):626-30. PMID: 23799460.
      View in: PubMed
    93. Saleem MM, Stowkowy J, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Addington J. Perceived discrimination in those at clinical high risk for psychosis. Early Interv Psychiatry. 2014 Feb; 8(1):77-81. PMID: 23773288.
      View in: PubMed
    94. Woods SW, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. Psychotropic medication use in youth at high risk for psychosis: comparison of baseline data from two research cohorts 1998-2005 and 2008-2011. Schizophr Res. 2013 Aug; 148(1-3):99-104. PMID: 23787224.
      View in: PubMed
    95. Greenwood TA, Swerdlow NR, Gur RE, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Ray A, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Light GA, Braff DL. Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry. 2013 May; 170(5):521-32. PMID: 23511790.
      View in: PubMed
    96. Walker EF, Trotman HD, Pearce BD, Addington J, Cadenhead KS, Cornblatt BA, Heinssen R, Mathalon DH, Perkins DO, Seidman LJ, Tsuang MT, Cannon TD, McGlashan TH, Woods SW. Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study. Biol Psychiatry. 2013 Sep 15; 74(6):410-7. PMID: 23562006.
      View in: PubMed
    97. Mondragón-Maya A, Solís-Vivanco R, León-Ortiz P, Rodríguez-Agudelo Y, Yáñez-Téllez G, Bernal-Hernández J, Cadenhead KS, de la Fuente-Sandoval C. Reduced P3a amplitudes in antipsychotic naïve first-episode psychosis patients and individuals at clinical high-risk for psychosis. J Psychiatr Res. 2013 Jun; 47(6):755-61. PMID: 23507048.
      View in: PubMed
    98. Addington J, Stowkowy J, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cannon TD. Early traumatic experiences in those at clinical high risk for psychosis. Early Interv Psychiatry. 2013 Aug; 7(3):300-5. PMID: 23343384.
      View in: PubMed
    99. Walder DJ, Holtzman CW, Addington J, Cadenhead K, Tsuang M, Cornblatt B, Cannon TD, McGlashan TH, Woods SW, Perkins DO, Seidman LJ, Heinssen R, Walker EF. Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome. Schizophr Res. 2013 Mar; 144(1-3):43-50. PMID: 23340377.
      View in: PubMed
    100. Addington J, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Addington JA, Cannon TD. North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment. Schizophr Res. 2012 Dec; 142(1-3):77-82. PMID: 23043872.
      View in: PubMed
    101. Mirzakhanian H, Singh F, Seeber K, Shafer KM, Cadenhead KS. A developmental look at the attentional system in the at risk and first episode of psychosis: age related changes in attention along the psychosis spectrum. Cogn Neuropsychiatry. 2013; 18(1-2):26-43. PMID: 22994363.
      View in: PubMed
    102. Perez VB, Shafer KM, Cadenhead KS. Visual information processing dysfunction across the developmental course of early psychosis. Psychol Med. 2012 Oct; 42(10):2167-79. PMID: 22717191.
      View in: PubMed
    103. Piskulic D, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, McGlashan TH. Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Res. 2012 Apr 30; 196(2-3):220-4. PMID: 22445704.
      View in: PubMed
    104. Singh F, Mirzakhanian H, Fusar-Poli P, de la Fuente-Sandoval C, Cadenhead KS. Ethical implications for clinical practice and future research in "at risk" individuals. Curr Pharm Des. 2012; 18(4):606-12. PMID: 22239594.
      View in: PubMed
    105. Cornblatt BA, Carrión RE, Addington J, Seidman L, Walker EF, Cannon TD, Cadenhead KS, McGlashan TH, Perkins DO, Tsuang MT, Woods SW, Heinssen R, Lencz T. Risk factors for psychosis: impaired social and role functioning. Schizophr Bull. 2012 Nov; 38(6):1247-57. PMID: 22080497.
      View in: PubMed
    106. Gee DG, Karlsgodt KH, van Erp TG, Bearden CE, Lieberman MD, Belger A, Perkins DO, Olvet DM, Cornblatt BA, Constable T, Woods SW, Addington J, Cadenhead KS, McGlashan TH, Seidman LJ, Tsuang MT, Walker EF, Cannon TD. Altered age-related trajectories of amygdala-prefrontal circuitry in adolescents at clinical high risk for psychosis: a preliminary study. Schizophr Res. 2012 Jan; 134(1):1-9. PMID: 22056201.
      View in: PubMed
    107. Jahshan C, Cadenhead KS, Rissling AJ, Kirihara K, Braff DL, Light GA. Automatic sensory information processing abnormalities across the illness course of schizophrenia. Psychol Med. 2012 Jan; 42(1):85-97. PMID: 21740622.
      View in: PubMed
    108. Domingues I, Alderman T, Cadenhead KS. Strategies for effective recruitment of individuals at risk for developing psychosis. Early Interv Psychiatry. 2011 Aug; 5(3):233-41. PMID: 21707939.
      View in: PubMed
    109. Cadenhead KS. Startle reactivity and prepulse inhibition in prodromal and early psychosis: effects of age, antipsychotics, tobacco and cannabis in a vulnerable population. Psychiatry Res. 2011 Jul 30; 188(2):208-16. PMID: 21555157.
      View in: PubMed
    110. Singh F, Pineda J, Cadenhead KS. Association of impaired EEG mu wave suppression, negative symptoms and social functioning in biological motion processing in first episode of psychosis. Schizophr Res. 2011 Aug; 130(1-3):182-6. PMID: 21549567.
      View in: PubMed
    111. Addington J, Cornblatt BA, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R. At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry. 2011 Aug; 168(8):800-5. PMID: 21498462.
      View in: PubMed
    112. Greenwood TA, Lazzeroni LC, Murray SS, Cadenhead KS, Calkins ME, Dobie DJ, Green MF, Gur RE, Gur RC, Hardiman G, Kelsoe JR, Leonard S, Light GA, Nuechterlein KH, Olincy A, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Freedman R, Braff DL. Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry. 2011 Sep; 168(9):930-46. PMID: 21498463.
      View in: PubMed
    113. Stone WS, Giuliano AJ, Tsuang MT, Braff DL, Cadenhead KS, Calkins ME, Dobie DJ, Faraone SV, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Olincy A, Radant AD, Roe AH, Schork NJ, Siever LJ, Silverman JM, Swerdlow NR, Thomas AR, Tsuang DW, Turetsky BI, Seidman LJ. Group and site differences on the California Verbal Learning Test in persons with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia (COGS). Schizophr Res. 2011 May; 128(1-3):102-10. PMID: 21288694.
      View in: PubMed
    114. Eslami A, Jahshan C, Cadenhead KS. Disorganized symptoms and executive functioning predict impaired social functioning in subjects at risk for psychosis. J Neuropsychiatry Clin Neurosci. 2011; 23(4):457-60. PMID: 22231319.
      View in: PubMed
    115. Cadenhead KS, Addington J, Cannon T, Cornblatt B, McGlashan T, Perkins D, Seidman L, Tsuang M, Walker E, Woods S, Heinssen R. Treatment history in the psychosis prodrome: characteristics of the North American Prodrome Longitudinal Study Cohort. Early Interv Psychiatry. 2010 Aug; 4(3):220-6. PMID: 20712727.
      View in: PubMed
    116. Seidman LJ, Giuliano AJ, Meyer EC, Addington J, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Bearden CE, Christensen BK, Hawkins K, Heaton R, Keefe RS, Heinssen R, Cornblatt BA. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Arch Gen Psychiatry. 2010 Jun; 67(6):578-88. PMID: 20530007.
      View in: PubMed
    117. Olincy A, Braff DL, Adler LE, Cadenhead KS, Calkins ME, Dobie DJ, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Wagner BD, Freedman R. Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia. Schizophr Res. 2010 Jun; 119(1-3):175-82. PMID: 20382002.
      View in: PubMed
    118. Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Meichle SP, Millard SP, Mintz J, Nuechterlein KH, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang MT, Turetsky BI, Tsuang DW. Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study. Psychophysiology. 2010 Sep; 47(5):846-56. PMID: 20374545.
      View in: PubMed
    119. Jahshan C, Heaton RK, Golshan S, Cadenhead KS. Course of neurocognitive deficits in the prodrome and first episode of schizophrenia. Neuropsychology. 2010 Jan; 24(1):109-120. PMID: 20063952.
      View in: PubMed
    120. Kaur T, Cadenhead KS. Treatment implications of the schizophrenia prodrome. Curr Top Behav Neurosci. 2010; 4:97-121. PMID: 21312398.
      View in: PubMed
    121. Walker EF, Cornblatt BA, Addington J, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Heinssen R. The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: a naturalistic study of the North American Prodrome Longitudinal Sample. Schizophr Res. 2009 Nov; 115(1):50-7. PMID: 19709859.
      View in: PubMed
    122. Woods SW, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull. 2009 Sep; 35(5):894-908. PMID: 19386578.
      View in: PubMed
    123. Turetsky BI, Greenwood TA, Olincy A, Radant AD, Braff DL, Cadenhead KS, Dobie DJ, Freedman R, Green MF, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Calkins ME. Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands. Biol Psychiatry. 2008 Dec 15; 64(12):1051-9. PMID: 18701089.
      View in: PubMed
    124. Horan WP, Braff DL, Nuechterlein KH, Sugar CA, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Olincy A, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Green MF. Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophr Res. 2008 Aug; 103(1-3):218-28. PMID: 18406578.
      View in: PubMed
    125. Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, Seidman LJ, Perkins D, Tsuang M, McGlashan T, Heinssen R. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry. 2008 Jan; 65(1):28-37. PMID: 18180426.
      View in: PubMed
    126. Greenwood TA, Braff DL, Light GA, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RE, Gur RC, Mintz J, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Schork NJ. Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry. 2007 Nov; 64(11):1242-50. PMID: 17984393.
      View in: PubMed
    127. Ballon JS, Dean KA, Cadenhead KS. Obstetrical complications in people at risk for developing schizophrenia. Schizophr Res. 2008 Jan; 98(1-3):307-11. PMID: 17961986.
      View in: PubMed
    128. Eastvold AD, Heaton RK, Cadenhead KS. Neurocognitive deficits in the (putative) prodrome and first episode of psychosis. Schizophr Res. 2007 Jul; 93(1-3):266-77. PMID: 17467955.
      View in: PubMed
    129. Kristensen K, Cadenhead KS. Cannabis abuse and risk for psychosis in a prodromal sample. Psychiatry Res. 2007 May 30; 151(1-2):151-4. PMID: 17383738.
      View in: PubMed
    130. Ballon JS, Kaur T, Marks II, Cadenhead KS. Social functioning in young people at risk for schizophrenia. Psychiatry Res. 2007 May 30; 151(1-2):29-35. PMID: 17383739.
      View in: PubMed
    131. Swerdlow NR, Sprock J, Light GA, Cadenhead K, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Gur RE, Mintz J, Olincy A, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophr Res. 2007 May; 92(1-3):237-51. PMID: 17346930.
      View in: PubMed
    132. Addington J, Cadenhead KS, Cannon TD, Cornblatt B, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Heinssen R. North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull. 2007 May; 33(3):665-72. PMID: 17255119.
      View in: PubMed
    133. Swerdlow NR, Light GA, Cadenhead KS, Sprock J, Hsieh MH, Braff DL. Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function. Arch Gen Psychiatry. 2006 Dec; 63(12):1325-35. PMID: 17146007.
      View in: PubMed
    134. Calkins ME, Dobie DJ, Cadenhead KS, Olincy A, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophr Bull. 2007 Jan; 33(1):33-48. PMID: 17035358.
      View in: PubMed
    135. Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Light GA, Meichle SP, Mintz J, Nuechterlein KH, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang MT, Turetsky BI, Tsuang DW. Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophr Res. 2007 Jan; 89(1-3):320-9. PMID: 17023145.
      View in: PubMed
    136. Fu EJ, Cadenhead KS. Progress in the Prospective Study of the Schizophrenia Prodrome. Curr Psychos Ther Rep. 2005 Dec 01; 3(4):169-174. PMID: 21691454.
      View in: PubMed
    137. Haroun N, Dunn L, Haroun A, Cadenhead KS. Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophr Bull. 2006 Jan; 32(1):166-78. PMID: 16207892.
      View in: PubMed
    138. Cadenhead KS, Light GA, Shafer KM, Braff DL. P50 suppression in individuals at risk for schizophrenia: the convergence of clinical, familial, and vulnerability marker risk assessment. Biol Psychiatry. 2005 Jun 15; 57(12):1504-9. PMID: 15953486.
      View in: PubMed
    139. Seeber K, Cadenhead KS. How does studying schizotypal personality disorder inform us about the prodrome of schizophrenia? Curr Psychiatry Rep. 2005 Mar; 7(1):41-50. PMID: 15717986.
      View in: PubMed
    140. Perry W, Minassian A, Cadenhead K, Sprock J, Braff D. The use of the Ego Impairment Index across the schizophrenia spectrum. J Pers Assess. 2003 Feb; 80(1):50-7. PMID: 12584067.
      View in: PubMed
    141. Cadenhead KS. Vulnerability markers in the schizophrenia spectrum: implications for phenomenology, genetics, and the identification of the schizophrenia prodrome. Psychiatr Clin North Am. 2002 Dec; 25(4):837-53. PMID: 12462863.
      View in: PubMed
    142. Cadenhead KS, Light GA, Geyer MA, McDowell JE, Braff DL. Neurobiological measures of schizotypal personality disorder: defining an inhibitory endophenotype? Am J Psychiatry. 2002 May; 159(5):869-71. PMID: 11986147.
      View in: PubMed
    143. Swerdlow NR, Eastvold A, Karban B, Ploum Y, Stephany N, Geyer MA, Cadenhead K, Auerbach PP. Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies. Psychopharmacology (Berl). 2002 May; 161(2):189-201. PMID: 11981599.
      View in: PubMed
    144. Cadenhead KS, Braff DL. Endophenotyping schizotypy: a prelude to genetic studies within the schizophrenia spectrum. Schizophr Res. 2002 Mar 01; 54(1-2):47-57. PMID: 11853978.
      View in: PubMed
    145. Granholm E, Cadenhead K, Shafer KM, Filoteo JV. Lateralized perceptual organization deficits on the global-local task in schizotypal personality disorder. J Abnorm Psychol. 2002 Feb; 111(1):42-52. PMID: 11866178.
      View in: PubMed
    146. Brenner CA, McDowell JE, Cadenhead KS, Clementz BA. Saccadic inhibition among schizotypal personality disorder subjects. Psychophysiology. 2001 May; 38(3):399-403. PMID: 11352128.
      View in: PubMed
    147. Braff DL, Geyer MA, Light GA, Sprock J, Perry W, Cadenhead KS, Swerdlow NR. Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr Res. 2001 Apr 15; 49(1-2):171-8. PMID: 11343875.
      View in: PubMed
    148. Swerdlow NR, Eastvold A, Uyan KM, Ploum Y, Cadenhead K. Matching strategies for drug studies of prepulse inhibition in humans. Behav Pharmacol. 2001 Feb; 12(1):45-52. PMID: 11270511.
      View in: PubMed
    149. Cadenhead KS, Swerdlow NR, Shafer KM, Diaz M, Braff DL. Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits. Am J Psychiatry. 2000 Oct; 157(10):1660-8. PMID: 11007721.
      View in: PubMed
    150. Light GA, Geyer MA, Clementz BA, Cadenhead KS, Braff DL. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications. Am J Psychiatry. 2000 May; 157(5):767-71. PMID: 10784470.
      View in: PubMed
    151. Cadenhead KS, Light GA, Geyer MA, Braff DL. Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. Am J Psychiatry. 2000 Jan; 157(1):55-9. PMID: 10618013.
      View in: PubMed
    152. Swerdlow NR, Geyer MA, Hartman PL, Sprock J, Auerbach PP, Cadenhead K, Perry W, Braff DL. Sex differences in sensorimotor gating of the human startle reflex: all smoke? Psychopharmacology (Berl). 1999 Sep; 146(2):228-32. PMID: 10525760.
      View in: PubMed
    153. Cadenhead KS, Perry W, Shafer K, Braff DL. Cognitive functions in schizotypal personality disorder. Schizophr Res. 1999 May 25; 37(2):123-32. PMID: 10374648.
      View in: PubMed
    154. Cadenhead KS, Carasso BS, Swerdlow NR, Geyer MA, Braff DL. Prepulse inhibition and habituation of the startle response are stable neurobiological measures in a normal male population. Biol Psychiatry. 1999 Feb 01; 45(3):360-4. PMID: 10023514.
      View in: PubMed
    155. Cadenhead KS, Serper Y, Braff DL. Transient versus sustained visual channels in the visual backward masking deficits of schizophrenia patients. Biol Psychiatry. 1998 Jan 15; 43(2):132-8. PMID: 9474445.
      View in: PubMed
    156. Cadenhead KS, Geyer MA, Butler RW, Perry W, Sprock J, Braff DL. Information processing deficits of schizophrenia patients: relationship to clinical ratings, gender and medication status. Schizophr Res. 1997 Nov 07; 28(1):51-62. PMID: 9428064.
      View in: PubMed
    157. Saccuzzo DS, Cadenhead KS, Braff DL. Backward versus forward visual masking deficits in schizophrenic patients: centrally, not peripherally, mediated? Am J Psychiatry. 1996 Dec; 153(12):1564-70. PMID: 8942452.
      View in: PubMed
    158. Cadenhead KS, Perry W, Braff DL. The relationship of information-processing deficits and clinical symptoms in schizotypal personality disorder. Biol Psychiatry. 1996 Nov 01; 40(9):853-8. PMID: 8896771.
      View in: PubMed
    159. Cadenhead K, Kumar C, Braff D. Clinical and experimental characteristics of "hypothetically psychosis prone" college students. J Psychiatr Res. 1996 Sep-Oct; 30(5):331-40. PMID: 8923337.
      View in: PubMed
    160. Swerdlow NR, Geyer MA, Perry W, Cadenhead K, Braff DL. Drug screening in "normal" controls. Biol Psychiatry. 1995 Jul 15; 38(2):123-4. PMID: 7578645.
      View in: PubMed
    161. Clementz BA, Reid SA, McDowell JE, Cadenhead KS. Abnormality of smooth pursuit eye movement initiation: specificity to the schizophrenia spectrum? Psychophysiology. 1995 Mar; 32(2):130-4. PMID: 7630977.
      View in: PubMed
    162. Cadenhead KS, Geyer MA, Braff DL. Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder. Am J Psychiatry. 1993 Dec; 150(12):1862-7. PMID: 8238643.
      View in: PubMed